Campuses: FH.com Home button

What's Happening

Back To All News

Technological Breakthrough for Early Detection of Lung Cancer

DELAND, Fla., February 26, 2016 – Florida Hospital DeLand offers a new technological breakthrough in the early detection of lung cancer. 
 
Called the SPiN Thoracic Navigation System by Veran Medical Technologies, the hospital’s newly acquired technology is a bronchial navigation system that helps physicians detect lung cancer earlier, which is the key to saving patients’ lives.
 
Lung cancer is the #1 cancer killer in Americans causing more deaths each year than breast, prostate, colon and pancreatic cancers combined. According to the American Cancer Society, more than 224,000 Americans are diagnosed with lung cancer each year.  The good news is that with early detection, the survival rate increases from 15 percent (stage IV) to as high as 92 percent (stage I).  
 
The SPiN Thoracic Navigation System is the only system in the world that allows physicians to accurately access small lung lesions via multiple approaches. This is important because it helps physicians detect lung cancer earlier and without the need for multiple hospital visits for diagnostic procedures.  
 
“Our new bronchial navigation system is a technological breakthrough that allows me to access all peripheral lung lesions, regardless of size or location,” said Dr. Christopher DiBello, Florida Hospital DeLand pulmonologist.  “With this new system, I can biopsy small nodules that we couldn’t reach before.  Being able to diagnose and treat these patients earlier leads to better patient outcomes.  Ultimately, this helps us save lives.”
 
“This is a huge benefit to our community, as nearly 20 percent of Volusia County adults smoke and cigarette smoking is linked to about 90 percent of lung cancers,” DiBello said. 
 
About Veran Medical Technologies
Veran Medical Technologies is a privately held medical device company headquartered in St. Louis, MO.  Veran delivers innovative thoracic navigation technologies that assist physicians in detecting and treating lung, liver and kidney cancers via a minimally invasive approach. For more information about Veran Medical Technologies, please contact TJ Meyer at tj.meyer@veranmedical.com.
 
About Florida Hospital DeLand
Florida Hospital DeLand is a member of Adventist Health System, a faith-based health care organization with 44 hospital campuses and nearly 8,300 licensed beds in 10 states. With 156-beds, Florida Hospital DeLand is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations and Disease-Specific Care Certified by the Joint Commission in Total Hip and Total Knee Replacement Surgery. Additionally, the hospital is Chest Pain Accredited with Percutaneous Coronary Intervention (PCI) and is also a Certified Stroke Center. For more information about Florida Hospital DeLand, visit www.fhdeland.org.